BACKGROUND: Cystatin C (Cys C) is measured by particle-enhanced nephelometric immunoassay (PENIA), particle-enhanced turbidimetric immunoassay (PETIA) and ELISA. AIM: To determine differences among these methods. METHOD: 80 normal human sera and 20 from patients with renal and/or heart disease were simultaneously assayed. Statistical analyses including receiver operating characteristics (ROC) of the three methods were compared. RESULTS: There was a highly significant correlation across the assay range between the ELISA and PENIA (r(2) = 0.94) and PETIA methods (r(2) = 0.95). Analysis of variance and bias were poor between the ELISA and the other two methods. Mean difference between ELISA and PETIA was 0.65 +/- 0.63 microg/ml, while it was 0.58 +/- 0.53 microg/ml between ELISA and PENIA. Accuracy (at 30% range) was 17 and 11% between ELISA and PETIA and ELISA and PENIA, respectively. Normalization of the ELISA by a factor of 0.66 improved this relationship. AUC of ROC curves of PENIA, ELISA and normalized ELISA to predict Cys C levels measured from PETIA were all above 0.87 (p = not significant between curves). Criterion values of ELISA*.66 method was close to PETIA measurements. CONCLUSION: There is a significant difference in measured human Cys C levels among the three methods, and normalization of ELISA narrows these differences.
No takes yet. Share an insight, caveat, or question.
Hossain et al. (2008) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: